CPC A61K 31/196 (2013.01) [A61K 9/0053 (2013.01); A61K 9/20 (2013.01); A61K 31/706 (2013.01); A61K 45/06 (2013.01); A61P 31/14 (2018.01); C07B 2200/13 (2013.01)] | 19 Claims |
1. A method of treating a long COVID symptom in a human subject in need thereof, comprising administering to the subject a compound according to Formula (I),
![]() a pharmaceutically acceptable salt, a solvate, a solvate of a salt, a hydrate thereof.
|